Patent: 5,256,410
✉ Email this page to a colleague
Summary for Patent: 5,256,410
Title: | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
Abstract: | Human squamous cell carcinoma is successfully treated by intralesional administration of recombinant human interferon alpha-2b. |
Inventor(s): | Tanner; Daniel J. (Brooklyn, NY), Peets; Edwin A. (New York, NY), Smiles; Kenneth A. (Novato, CA) |
Assignee: | Schering Corporation (Kenilworth, NJ) |
Application Number: | 07/684,964 |
Patent Claims: | see list of patent claims |
Details for Patent 5,256,410
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2010-10-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2010-10-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2010-10-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |